Navigation Links
Amylin Pharmaceuticals Reports 2007 Financial Results
Date:1/28/2008

ember 31, 2007, compared to $63.8 million for the same period in 2006.

Net loss was $76.9 million, or $0.57 per share, for the quarter ended December 31, 2007, compared to a net loss of $58.4 million, or $0.45 per share, for the same period in 2006.

Fourth quarter highlights

Highlights of Amylin's fourth quarter include the following:

-- Positive results from a 24-week study of monotherapy, or stand alone,

BYETTA in drug nave patients with type 2 diabetes. The Company plans

for a regulatory submission for a monotherapy indication to the U.S.

Food and Drug Administration, or FDA, in the first half of 2008.

-- Positive results from a 30-week comparator study of exenatide once

weekly injection and BYETTA taken twice daily in patients with type 2

diabetes. The Company anticipates a regulatory submission to the FDA by

the end of the first half of 2009.

-- Positive results from a 24-week proof-of-concept study with the

combination treatment of pramlintide, an analog of human amylin, and

metreleptin, an analog of human leptin in overweight or obese subjects,

validating the Company's novel integrated neurohormonal treatment of

obesity (INTO) strategy. The Company plans for additional clinical

development in 2008, including the initiation of a Phase 2B study.

Year ended December 31, 2007

Total revenue for the year ended December 31, 2007 was $781.0 million. This includes net product sales of $701.5 million, consisting of $636.0 million for BYETTA and $65.5 million for SYMLIN. This compares to total revenue of $510.9 million for the same period in 2006, including net product sales of $474.0 million consisting of $430.2 million for BYETTA and $43.8 million for SYMLIN.

Revenues under collaborative agreements were $79.5 million for the year ended December 31, 2007, compared to $36.8 million for the same period in 20
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
2. Amylin Pharmaceuticals to Present at Research & Development Day
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Webcast Third Quarter Results
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
7. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
8. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
9. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
10. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:7/22/2014)... 22, 2014 Cloud+MD Office 2.0 ... interoperable suite of medical software and services, designed ... providers, that produces “Actionable Information” to help Independent ... Systems and Billing Services optimize a wide range ... Quality, Greater Efficiency, Noticeable Cost Reductions and Better ...
(Date:7/22/2014)... For the past nine years, the LIVESTRONG Foundation ... tandem to help thousands of cancer patients and survivors ... help survivors connect to resources dealing with work discrimination ... to include referrals from PAF to LIVESTRONG to help ... emotional, and financial issues that accompany a diagnosis. ...
(Date:7/22/2014)... 22, 2014 Joining Conquer Paralysis Now as ... the next decade is Paralympic silver medalist and quadriplegic Jennifer ... became a quadriplegic from a spinal cord injury in 1998. ... a cure for paralysis. , “People define cure differently,” French ... something else. We have the image in our minds of ...
(Date:7/22/2014)... Hills, CA (PRWEB) July 22, 2014 ... document management and workflow solutions, announced today their Gold ... 28 – 31 at Mandalay Bay Hotel and Casino ... Sage customers, Sage Summit draws thousands interested in taking ... leaders, learn how to solve business problems and educate ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Cloud-MD Software will soon Receive MU2 Certification 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Paralympian Jen French Announced as Conquer Paralysis Now’s First Champion 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3
... that it's never too late for a person to start ... ,The researchers particularly taking into consideration the people who ... the exercise need not be of any strenuous nature but ... Dr Dietrich Rothenbacher, an epidemiologist at the University of Heidelberg ...
... variations on how hospitals spend for meals for their ... are spending four times the amounts spent by others.// ... average of ?61 on patients' meals per week as ... to The Scotsman newspaper, there are huge variations reported. ...
... be successfully located with or in pediatric practices, ... Medical Center and the N.C. Chapter of the ... journal Clinical Pediatrics, the researchers said, “With the ... mental health disorders in primary health care settings, ...
... therapy, when used to treat patients who are in ... chances of survival//, say researchers at Rhode Island ... patients over seven years, the median survival rate at ... to 42 months when thermal ablation was followed by ...
... his colleagues working in the laboratory of Dr. Stanley ... that controls// the sensitivity of human cancer cells to ... of research striving towards increased effectiveness of ... in advance of its scheduled August 1 publication date ...
... devised a chip that can be implanted into a patient's arm, ... medical personnel to easily get hold of patients' medical data. , ... have launched the program to test this product, which will go ... ,The chip can be interpreted with the ...
Cached Medicine News:Health News:Exercise Activities Helps To Avoid Heart Ailment 2Health News:Mental Health Providers Can Be Successfully Located With Pediatricians 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 3
(Date:7/21/2014)... 21, 2014 Companies that supply Durable ... often contact consumers directly about purchasing such supplies ... use. The American Osteopathic Association,s House of Delegates ... from companies that supply Durable Medical Equipment unless ... the physician and the patient. ...
(Date:7/21/2014)... , July 21, 2014 /PRNewswire-iReach/ -- Top Brooklyn ... Pediatrics responds to an article, which suggests that caffeine ... Logo - http://photos.prnewswire.com/prnh/20140718/128611 A ... giving coffee to children, but now it happens rather ... A new study, published in the journal Pediatrics, discussed ...
(Date:7/21/2014)... LOS ANGELES , July 21, 2014 ... Procurement Agency (LOPA) is utilizing the CompuMed, ... (OPO) Solution to improve donor organ recovery. ... platform to provide real-time access to its ... critical care consulting.      (Logo: ...
Breaking Medicine Technology:American Osteopathic Association Calls for Eliminating Unsolicited Requests to Purchase Medical Equipment 2Dr. Michael Gabriel a Brooklyn Pediatrician Comments on an Article, Which Suggests Caffeine May Be Dangerous for Children 2Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 2Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 3
HemataSTAT II has a manual reader. It uses both 0.5 and 1.1 ID capillary tubes., , Spins in just 60 seconds , Built-in reader with LCD display , Accuracy comparable to NCCLS reference method , Lid lo...
... the easiest test to use on the market. ... no hands-on time. Critical care instructions can be ... the pediatrician's office. Valuable information can be obtained ... Now the focus can be on the results ...
The QuickScreen Pro Multi Drug Screening Test is a rapid, self-timing, qualitative immunoassay for,the detection of drugs of abuse in urine....
... Tests are qualitative immunoassays for detecting elevated levels ... is fast and results are easy to interpret. ... darker than the control band, then ovulation will ... If the test band does not appear or ...
Medicine Products: